The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
Advertisement
The Scientist
Most Recent
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
Collective cell migration relies on a directional signal that comes from the moving cluster, rather than from external cues.
Watch the cell transplant experiments in zebrafish that suggest certain embryonic cells rely on intrinsic directional cues for collective migration.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.
Academics get paid handsome fees to consult with the financial industry, but run the risk of revealing confidential information that leads to illicit gains.
Two new studies claim that a shoddy test may have caused Alzheimer’s drugs to fail in clinical trials.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
